Skip tomain content

Compound for modulating rlr, tlr, oas and/or oncostatin m pathways, use thereof for preparing a medicine, composition, method for modulating said pathways and method of treatment

Inventor
Chudzinski-Tavassi, Ana Marisa ;  Chammas, Roger;  Goldfeder, Maurício Barbugiani;  De Ocesano-Pereira, Carlos ;  Lichtenstein, Flavio ;  Souza, Jean Gabriel de ;  Morais, Kátia Luciano Pereira 
Butantan affiliation
(LDI) Laboratório de Desenvolvimento e Inovadfederção Industrial;  (CENTD) Centro de Excelência para Descoberta de Alvos Moleculares 
Publication type
Patent
Language
English
Access rights
Restricted access
Appears in Collections:
Abstract
The invention falls within the fields of pharmaceutical sciences, immunology and methods of treatment of cancer Methods. More specifically, the invention relates to a compound for modulating one or more innate immune pathways selected from RLR, TLR, OAS and/or oncostatin M, said compound being amblyomin-X or peptides derived from amblyomin-X. Use of said compound for preparing medicines; a pharmaceutical composition comprising said compound, a method for modulating said pathways in vitro and a method of treatment are also described.
Link to cite this reference
https://repositorio.butantan.gov.br/handle/butantan/4323
Issue Date
2022

Show full item record

The access to the publications deposited in this repository respects the licenses from journals and publishers.